The objective of this study is to assess the impact of a 3-month daily intake of 4 grams of ω-3PUFA on insulin sensitivity in individuals with obesity who have previously been diagnosed with insulin resistance and systemic inflammation. The gene discussed is INS; the disease is obesity disorder.